MIRA INFORM REPORT

 

 

Report Date :

17.10.2013

 

IDENTIFICATION DETAILS

 

Name :

KOPRAN LIMITED

 

 

Registered Office :

Parijat House, 1076, Dr. E. Moses Road, Worli, Mumbai - 400018, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2013

 

 

Date of Incorporation :

26.04.1958

 

 

Com. Reg. No.:

11-011078

 

 

Capital Investment / Paid-up Capital :

Rs.476.289 Millions

 

 

CIN No.:

[Company Identification No.]

L24230MH1958PLC011078

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

MUMK01878C

 

 

Legal Form :

A Public Limited Liability Company. The company’s Shares are Listed on the Stock Exchanges.

 

 

Line of Business :

The Subject is engaged primarily in pharmaceuticals business.

 

 

No. of Employees :

Not Available

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (46)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 5120000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually correct

 

 

Litigation :

Exist

 

 

Comments :

Subject is an established company having satisfactory track record.

 

Overall financial of the company appears to be satisfactory.

 

Trade relations are fair. Business is active. Payment terms are usually correct.

 

The company can be considered for business dealings at usual trade terms and conations. 

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31st, 2013

 

Country Name

Previous Rating

(31.12.2012)

Current Rating

(31.03.2013)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INDIAN ECONOMIC OVERVIEW

 

We are living in a world where volatility and uncertainty have become the New Normal. We saw a change of government in countries like Tunisia, Egypt, Libya and Vietnam. Once powerful countries in Europe are now fighting for bankruptcy. We have taken growth in the developing part of the world for granted but economic growth in China and India has begun to slow. Companies that were synonymous with their product categories just a few years ago are now no longer in existence. Kodak, the inventor of the digital camera had to wind up its operations, HMV, the British entertainment retailing company and Borders, once the second largest bookstore have shut down due to their inability to evolve their business models with the changing time. Readers’ Digest, Thomson Register are no more !

 

There is another megatrend happening. The World order is changing as economic power shifts from West to East. According to McKinsey study, it took Britain more than 100 years to double its economic output per person during its industrial revolution and the US later took more than 50 years to do the same. More than a century later, China and India have doubled their GDP per capital in 12 and 18 years respectively. By 2020, emerging Asia will become the world’s largest consuming block, overtaking North America.

 

The years after the outbreak of the global financial crisis, the world economy continues to remain fragile. The Indian economy demonstrated remarkable resilience in the initial years of the contagion but finally lost ground last year. GDP growth slowed down. Currency has been weakening. There is a marked deceleration in agriculture, industry and services. Dampening sentiment led to a cut-back in investment as well as private consumption expenditure.  Inflation remained at high levels fuelled by the pressure from the food and fuel sectors. The large fiscal and current account deficit s continued to cause grave concern. It is imperative that India regains its growth trajectory of 8-9 % sooner than later. This is crucially important given the need to create gainful livelihood opportunities for the millions living in poverty as also the large contingent of young people joining the job market every year.

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

 

LOCATIONS

 

Registered Office :

Parijat House, 1076, Dr. E. Moses Road, Worli, Mumbai - 400018, Maharashtra,  India

Tel. No.:

91-22-24964480-85/ 43661111

Fax No.:

91-22-24950363

E-Mail :

kopran@giasbm01.vsnl.net.in

kopran@bom4.vsnl.net.in

ss@kopran.com

abhinav@kopran.com

Website :

http://www.kopran.com

 

 

Factory 1 :

Formulation Unit

Village Savroli, Taluka Khalapur, Khopoli, District Raigad – 410202, Maharashtra, India

Tel. No :

91-2192-274500

Fax No :

91-2192-274025

 

 

Factory 2 :

API Unit

K-4, Additional MIDC, Village Birwadi, Mahad – 403201 District Raigad, Maharashtra, India

Tel. No :

91-2145-251101-04

Fax No :

91-2145-251100

 

 

DIRECTORS

 

As on: 31.03.2013

 

Name :

Mr. Mr. Susheel G. Somani

Designation :

Chairman

Qualification :

MSC

 

 

Name :

Mr. Surendra Somani

Designation :

Executive Vice-Chairman

 

 

Name :

Dr. A. K. Mehta

Designation :

Director

 

 

Name :

Mr. V. N. Khanna

Designation :

Director

 

 

Name :

Mr. Ajit Jain

Designation :

Executive Director and Chief Operating Officer

Qualification :

FCA

 

 

Name :

Mr. Amit Rajan

Designation :

Director

Qualification :

M. Tech, (I.I.T. Delhi)

 

 

Name :

Mr. Vijay Kumar Bhandari

Designation :

Director (Appointed w.e.f. 12th February, 2013)

Qualification :

B.Com(Hons), FCA

 

 

KEY EXECUTIVES

 

Name :

Mr. Abhinav Mathur

Designation :

Company Secretary

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on: 30.06.2013

 

Category of Shareholders

No. of Shares

Percentage of Holding

(A) Shareholding of Promoter and Promoter Group

 

 

http://www.bseindia.com/include/images/clear.gif(1) Indian

 

 

http://www.bseindia.com/include/images/clear.gifIndividuals / Hindu Undivided Family

5522700

14.14

http://www.bseindia.com/include/images/clear.gifBodies Corporate

9570238

24.51

http://www.bseindia.com/include/images/clear.gifSub Total

15092938

38.65

http://www.bseindia.com/include/images/clear.gif(2) Foreign

 

 

Total shareholding of Promoter and Promoter Group (A)

15092938

38.65

(B) Public Shareholding

 

 

http://www.bseindia.com/include/images/clear.gif(1) Institutions

 

 

http://www.bseindia.com/include/images/clear.gifMutual Funds / UTI

500

0.00

http://www.bseindia.com/include/images/clear.gifFinancial Institutions / Banks

1039893

2.66

http://www.bseindia.com/include/images/clear.gifForeign Institutional Investors

300

0.00

http://www.bseindia.com/include/images/clear.gifSub Total

1040693

2.67

http://www.bseindia.com/include/images/clear.gif(2) Non-Institutions

 

 

http://www.bseindia.com/include/images/clear.gifBodies Corporate

3063293

7.84

http://www.bseindia.com/include/images/clear.gifIndividuals

 

 

http://www.bseindia.com/include/images/clear.gifIndividual shareholders holding nominal share capital up to Rs. 0.100 Million

11094030

28.41

http://www.bseindia.com/include/images/clear.gifIndividual shareholders holding nominal share capital in excess of Rs. 0.100 Million

7954901

20.37

http://www.bseindia.com/include/images/clear.gifAny Others (Specify)

803621

2.06

http://www.bseindia.com/include/images/clear.gifTrusts

4500

0.01

http://www.bseindia.com/include/images/clear.gifClearing Members

30374

0.08

http://www.bseindia.com/include/images/clear.gifNon Resident Indians

768747

1.97

http://www.bseindia.com/include/images/clear.gifSub Total

22915845

58.68

Total Public shareholding (B)

23956538

61.35

Total (A)+(B)

39049476

100.00

(C) Shares held by Custodians and against which Depository Receipts have been issued

0

0.00

http://www.bseindia.com/include/images/clear.gif(1) Promoter and Promoter Group

0

0.00

http://www.bseindia.com/include/images/clear.gif(2) Public

0

0.00

http://www.bseindia.com/include/images/clear.gifSub Total

0

0.00

Total (A)+(B)+(C)

39049476

0.00

 

 

BUSINESS DETAILS

 

Line of Business :

The Subject is engaged primarily in pharmaceuticals business.

 

 

GENERAL INFORMATION

 

No. of Employees :

Not Available

 

 

Bankers :

·         State Bank of India

·         The Federal Bank Limited

·         Kapol Co-Operative Bank Limited

·         The Saraswat Co-Operative Bank Limited

·         The New India Co-Operative Bank Limited

·         Mandvi Co-Operative Bank Limited

 

 

Facilities :

(Rs. In Millions)

Secured Loan

As on

31.03.2013

As on

31.03.2012

LONG-TERM BORROWINGS

 

 

Rupee loans

 

 

Term loans from banks

27.831

30.000

Working capital term loans (WCTL) from banks

0.000

24.712

Vehicles finance loans

1.614

0.143

SHORT-TERM BORROWINGS

 

 

Cash credit / packing credit *

158.352

216.546

Buyers credit

85.382

94.707

 

 

 

Total

273.179

366.108

 

Notes:

 

(a) Term loans from banks include term loan of Rs. 10.000 Millions which carries interest base rate +4.50% p.a. and is repayable in 10 equal quarterly installments of Rs. 5.000 Millions from April, 2012. The loan is secured by first mortgage charge on the company's entire fixed assets on pari-passu basis with other working capital consortium banks and second charge on current assets of the company on pari-passu basis.

 

(b) Term loans from banks include term loan of Rs. 17.831 Millions which carries interest base rate +4.50% p.a. and is repayable in 10 equal quarterly installments of Rs. 5.000 Millions from June, 2013. The loan is secured by first mortgage charge on the company's entire fixed assets on pari-passu basis with other working capital consortium banks and second charge on current assets of the company on pari-passu basis.

 

(c) WCTL carried interest base Rate + 4.60% p.a. to 5.75% P.a. during the year 2012-13 and is repayable in 41 equal monthly installments of Rs. 4.100 Millions from April, 2010. The loan is secured by a pari-passu first charge by way of mortgage on all the immovable properties and by way of hypothecation on all the movable fixed assets of the company both present and future and second charge on current assets of the company and guaranteed by three Directors/ Promoters jointly and severally also by a corporate guarantee of Kopran Research Laboratories Limited (subsidiary company).

 

(d) Vehicle finance loan carries interest @ 10.73% to 12.40% p.a. and is repayable in 35 equal monthly installments. The loans is secured by hypothecation of vehicles.

 

(e) *Cash credit / Packing credit facilities availed from banks are secured by hypothecation of inventories and book debts (present and future) also second charge by way of mortgage on all immoveable properties and by way of hypothecation on all the moveable fixed assets of the company both present and future and guaranteed by director / promoter jointly and severally. The said facility is repayable on demand.

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Batliboi and Purohit

Chartered Accountants

Address :

Mumbai, Maharashtra, India

 

 

Wholly Owned Subsidiary :

·         Kopran Research Laboratories Limited

·         Kopran (H.K) Limited

·         Kopran Lifesciences Limited

 

 

CAPITAL STRUCTURE

 

As on: 15.09.2012

 

Authorised Capital : Rs.700.000 Millions

 

Issued, Subscribed & Paid-up Capital : Rs.476.326 Millions

 

 

As on: 31.03.2013

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

56250000

Equity Shares

Rs.10/- each

Rs.562.500 Millions

13750000

10% Non convertible Non cumulative redeemable preference shares

Rs.10/- each

Rs.137.500 Millions

 

 

 

 

 

Total

 

Rs.700.000 Millions

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

39052602

Equity Shares

Rs.10/- each

Rs.390.526 Millions

8580000

10% Non convertible Non cumulative redeemable preference shares

Rs.10/- each

Rs.85.800 Millions

 

Less: Calls in-Arrears (Other than Director's)

 

Rs.0.037 Million

 

 

 

 

 

Total

 

Rs.476.289 Millions

 

 

a) Terms / Rights attached to equity Shares

 

The Company has only one class of equity shares having a par value of Rs.10/- per share. Each holder of equity shares is entitled to one vote per share. The Company declares and pays dividends in Indian rupees.

 

In the event of liquidation of the Company, the holders of equity shares will be entitled to receive remaining assets of the company, after distribution of all preferential amounts. The distribution will be in the proportion to the number of equity shares held by the shareholders.

 

 

b) Terms of redemption of preference shares

 

55,80,000 10% Non convertible non cumulative redeemable preference shares of Rs. 10 each are redeemable at par on 15th March, 2025 or at any time after one year from 31st March, 2012 at the option of the company.

 

10,00,000 10% Non convertible non cumulative redeemable preference Shares of Rs. 10 each are redeemable at par on 28th June, 2019 or at any time after one year from 31st March, 2012 at the option of the company.

 

20,00,000 10% Non convertible non cumulative redeemable Preference Shares of Rs. 10 each are redeemable at par on 22nd June, 2019 or at any time after one year from 31st March, 2012 at the option of the company.

 

 

c) Shares held by holding/ultimate holding company and/or their subsidiaries/associates

 

None of the shares of the Company are held by the subsidiaries, associates or joint ventures of the company.

 

 

d) Details of shareholders holding more than 5% shares in the company

 

 

As at 31st March, 2013

Equity Shares of Rs. 10/- each fully paid

Number of Shares

% holding

Ponorama Finvest Private Limited

3800000

9.73%

Sarvamangal Mercantile Company Limited

2167956

5.55%

 

 

 

10% Non convertible non cumulative redeemable preference shares of Rs.10 each

 

 

Sarvamangal Mercantile Company Limited

6380000

74.00%

Kopran Laboratories Limited

1000000

12.00%

Susheel G. Somani and Mridula Somani

1200000

14.00%

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2013

31.03.2012

31.03.2011

EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

476.289

476.289

476.289

(b) Reserves & Surplus

804.822

684.192

622.516

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

1281.111

1160.481

1098.805

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

694.819

645.862

732.505

(b) Deferred tax liabilities (Net)

0.000

0.000

0.000

(c) Other long term liabilities

0.000

0.000

0.000

(d) long-term provisions

35.654

31.318

28.066

Total Non-current Liabilities (3)

730.473

677.180

760.571

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

243.734

311.253

304.754

(b) Trade payables

468.333

417.092

306.406

(c) Other current liabilities

205.583

226.914

186.121

(d) Short-term provisions

1.190

1.149

1.840

Total Current Liabilities (4)

918.840

956.408

799.121

 

 

 

 

TOTAL

2930.424

2794.069

2658.497

 

 

 

 

ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

1061.800

1116.022

1121.102

(ii) Intangible Assets

0.000

0.000

0.000

(iii) Capital work-in-progress

9.268

0.000

0.400

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

68.710

68.710

68.710

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

559.664

543.149

530.287

(e) Other Non-current assets

0.000

0.000

26.637

Total Non-Current Assets

1699.442

1727.881

1747.136

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

367.405

351.470

321.112

(c) Trade receivables

496.098

375.162

333.632

(d) Cash and cash equivalents

36.327

95.155

7.459

(e) Short-term loans and advances

331.152

244.401

249.158

(f) Other current assets

0.000

0.000

0.000

Total Current Assets

1230.982

1066.188

911.361

 

 

 

 

TOTAL

2930.424

2794.069

2658.497

 

 

 

 

 


PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2013

31.03.2012

31.03.2011

 

SALES

 

 

 

 

 

Income

2502.192

1989.054

1923.783

 

 

Other Income

17.198

55.624

63.815

 

 

TOTAL                                     (A)

2519.390

2044.678

1987.598

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of materials consumed

1582.263

1194.559

1299.572

 

 

Purchase of Traded goods

0.039

4.273

27.980

 

 

Changes in inventories of finished goods and work in progress

(40.806)

69.834

(84.836)

 

 

Employee benefit expense

204.824

175.196

173.404

 

 

Other expenses

412.929

328.357

321.729

 

 

TOTAL                                     (B)

2159.249

1772.219

1737.849

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

360.141

272.459

249.749

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

118.758

96.627

86.089

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

241.383

175.832

163.660

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

120.753

114.157

112.333

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                               (G)

120.630

61.675

51.327

 

 

 

 

 

Less

TAX                                                                  (H)

0.000

0.000

(2.705)

 

 

 

 

 

 

PROFIT AFTER TAX (G-H)                                (I)

120.630

61.675

54.032

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

FOB value of exports

1833.710

1235.200

1139.751

 

TOTAL EARNINGS

1833.710

1235.200

1139.751

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw / Packing materials

677.766

502.862

514.871

 

 

Capital Goods

3.873

3.407

9.650

 

TOTAL IMPORTS

681.639

506.269

524.521

 

 

 

 

 

 

Earnings Per Share (Rs.)

3.09

1.58

1.32

 

 

QUARTERLY RESULTS

 

PARTICULARS

 

 

 

30.06.2013

 

 

 

1st Quarter

Net Sales

 

 

597.000

Total Expenditure

 

 

518.700

PBIDT (Excl OI)

 

 

78.300

Other Income

 

 

10.600

Operating Profit

 

 

88.900

Interest

 

 

30.700

Exceptional Items

 

 

0.000

PBDT

 

 

58.200

Depreciation

 

 

30.300

Profit Before Tax

 

 

27.900

Tax

 

 

0.000

Provisions and contingencies

 

 

0.000

Profit After Tax

 

 

27.900

Extraordinary Items

 

 

0.000

Prior Period Expenses

 

 

0.000

Other Adjustments

 

 

0.000

Net Profit

 

 

27.900

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2013

31.03.2012

31.03.2011

PAT / Total Income

(%)

4.79

3.02

2.72

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

4.82

3.10

2.67

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

4.23

2.26

1.98

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.09

0.05

0.05

 

 

 

 

 

Debt Equity Ratio

(Total Debt/Networth)

 

0.73

1.48

0.94

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.34

1.11

1.14

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No

9]

Name of person contacted

No

10]

Designation of contact person

No

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

--

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

--

22]

Litigations that the firm / promoter involved in

Yes

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

--

26]

Buyer visit details

--

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

No

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

 

UNSECURED LOAN

(Rs. In Millions)

Particular

As on

31.03.2013

As on

31.03.2012

LONG-TERM BORROWINGS

 

 

Other*

80.000

0.000

Inter corporate deposits

585.374

591.007

 

 

 

Total

665.374

591.007

 

Notes:

 

* Loans from others carries interest @ 13.50% p.a. and is repayable in 10 equal quarterly installments from December, 2013. The loan is secured by personal guarantee and mortgage/ pledge of certain assets of promoters and directors.

 

 

LITIGATION DETAILS:

Case Details

Bench: - Bombay

Loading No:- ITXAL/677/2011

Filing Date:- 18/05/2011

Reg. No:- ITAX/1599/2011

Reg. Date:- 19.07.2011

 

 

 

 

Petitioner:-

COMMISSIONER OF INCOME TAX CENTRAL

Respondent:-

M/S KOPRAN LTD.

Petn.Adv:-

J.S. SALUJA

Resp.Adv.:-

ARVIND RATHOD AND COMPANY

District:

 MUMBAI

Bench:

 DIVISION

Status:-

Admitted (Unready)

Category:-

TAX APPEALS

Next Date:-

26/07/2012

Stage:-

 

Last Coram:-

HON’BLE SHRI JUSTICE S.J. VAZIFDAR

HON’BLE SHRI JUSTICE M.S. SANKLECHA

 

 

FINANCIAL PERFORMANCE

 

Standalone

 

The company achieved total revenue of Rs. 2519.400 Millions in the current year as against total revenue of Rs. 2044.700 Millions in the previous year. During the year, the company earned net profit of Rs. 120.600 Millions (Previous Year: Rs. 61.700 Millions), thus achieving a growth of 96% in profits.

 

 

MANAGEMENT DISCUSSION AND ANALYSIS

 

Industrial Overview

 

The Indian Pharmaceutical Industry has gained recognition in the global market. India is one of the largest suppliers of Generic Products in the world. The Indian Pharmaceutical manufacturers continue to attract global attention due to its proficient R and D personnel, Contract Manufacturing and Clinical trial facilities. India has been ranked as the highest amongst third world countries and is the most preferred country for sourcing for the Regulated markets like the US and Europe.

 

Company Strategy

 

The Company has taken up several new projects and also produced new products. The Company has successfully registered its products across the African and South East Asian markets. Various Drug Master Files and Dossiers of Finished Dosage Forms are being filed for the Regulated markets giving an opportunity to have a balanced business between the Regulated markets and the rest of the world. New markets are being explored continuously for growth purpose.

 

The Company has already launched new products in the critical segments like Oncology and Penems including the Chronic and CNS groups. The Company is moving towards vertically integrated models of operations, especially in light of oncology products.

 

 

FINANCIAL PERFORMANCE AND REVIEW

 

During the year, the company achieved a total revenue of Rs. 2519.300 Millions (Previous Year Rs. 2044.700 Millions) and a Profit before Depreciation, Interest and Tax of Rs. 360.100 Millions (Previous Year: Rs. 272.500 Millions) and there is a Net Profit of Rs. 120.600 Millions (Previous Year: Rs. 61.700 Millions).

 

There was 96 % increase in profitability of the company during Financial Year 2012-13 in comparison to Previous Year 2011-12 .Ratio of domestic and international sales revenue amounted to the ratio of 23:77.

 

 

INDEX OF CHARGES

 

S.No.

Charge ID

Date of Charge Creation/Modification

Charge amount secured

Charge Holder

Address

Service Request Number (SRN)

1

10428024

29/04/2013

110,000,000.00

THE FEDERAL BANK LIMITED

MUMBAI FORT,32,BOMBAY SAMACHAR MARG, FORT, MUMBAI, MAHARASHTRA - 400001, INDIA

B75858308

2

10421518

30/03/2013

90,000,000.00

THE FEDERAL BANK LIMITED

MUMBAI-FORT, 32,BOMBAY SAMACHAR MARG, FORT, MUMBAI , MAHARASHTRA - 400001, INDIA

B73690273

3

10406606

28/01/2013

50,000,000.00

STATE BANK OF INDIA

COMMERCIAL BRANCH (ADVANCES), N. G. N. VAIDYA MARG, BANK STREET, HORNIMAN CIRCLE, P.B. NO. 10141, FORT, MUMBAI, MAHARASHTRA - 400001, INDIA

B69030146

4

10392397

20/11/2012

30,000,000.00

THE FEDERAL BANK LIMITED

MUMBAI-FORT,32,BOMBAY SAMACHAR MARG, FORT, MUMBAI, MAHARASHTRA - 400001, INDIA

B64300460

5

10302578

29/04/2013 *

275,000,000.00

THE FEDERAL BANK LIMITED

MUMBAI-FORT,32,BOMBAY SAMACHAR MARG, FORT, MUMBAI, MAHARASHTRA - 400001, INDIA

B75859488

6

10058570

04/07/2007

80,000,000.00

CANARA BANK

TAMARIND LANE BR., CALCOT HOUSE, TAMARIND LANE, MUMBAI, MAHARASHTRA - 400023, INDIA

A18114975

7

90243976

10/08/2005

26,000,000.00

STATE BANK OF INDIA

COMMERCIAL BR.;G;N; VAIDYA MARG, MUMBAI, MAHARASHTRA - 400001, INDIA

-

8

90223577

04/05/2005

100,000,000.00

UTI BANK LIMITED

NO.9 MAG ROAD; BANGALORE, KARNATAKA - 560001, INDIA

-

9

90223225

10/08/2005 *

199,500,000.00

THE FEDERAL BANK LTD

NARIMAN BHAVAN FIRST FLOOR NARIMAN POINT, MUMBAI, MAHARASHTRA - 400021, INDIA

-

10

90223155

18/08/2011 *

695,000,000.00

STATE BANK OF INDIA

COMMERCIAL BRANCH,, N. G. N. VAIDYA MARG, MUMBAI, MAHARASHTRA - 400023, INDIA

B20235362

11

90222893

28/02/2000 *

186,000,000.00

STATE BANK OF INDIA

COMMERCIAL BRANCH, JUSTICE G.N. VAIDYA MARG, MUMBAI, MAHARASHTRA - 400023, INDIA

 

12

90220294

20/01/1998

460,000,000.00

THE BANK OF NOVA SCOTIA

MITTAL TOWER, NARIMAN POINT, MUMBAI, MAHARASHTRA - 400021, INDIA

 

13

90222849

20/06/2000 *

460,000,000.00

THE BANK OF NOVA SCOTIA

MITTAL TOWER, NARIMAN POINT, BOMBAY, MAHARASHTRA - 400021, INDIA

 

14

90222841

22/12/1997

3,000,000,000.00

IMPORT EXPORT BANK OF INDIA

CENTRE ONE ; WORLD TRADE CENTRE, CUFFE PARADE, MUMBAI, MAHARASHTRA - 400005, INDIA

 

15

90222797

02/09/1997

36,000,000.00

EXPORT-IMPORT BANK OF INDIA

CENTRE ONE; WORLD TRADE CENTRE, CUFFE PARADE, BOMBAY, MAHARASHTRA - 400005, INDIA

 

16

90222771

10/06/1997

337,259.00

THE SARASWAT CO.OPERATIVE BANK LTD.

APSARA CINEMA BLDG. ; 2ND FLOOR, GRANT ROAD; DR. D.B. MARG, BOMBAY, MAHARASHTRA - 400007, INDIA

 

17

90222763

10/05/1997

1,440,000.00

THE SARASWAT CO.OPERATIVE BANK LTD.

APSARA CINEMA BLDG. ; 2ND FLOOR, GRANT ROAD; DR. D.B. MARG, BOMBAY, MAHARASHTRA - 400007, INDIA

 

18

90222749

31/12/2001 *

1,800,000,000.00

STATE BANK OF INDIA

COMMERCIAL BRANCH, JUSTICE G.N. VAIDYA MARG, BOMBAY, MAHARASHTRA - 400023, INDIA

 

19

90222742

27/07/1998 *

100,000,000.00

DRESDENER BANK AG

239; BACKBAY RECLAMATION; UNION BANK BHAVAN, NARIMAN POINT, BOMBAY, MAHARASHTRA - 400021, INDIA

 

20

90222655

06/07/1996

473,000.00

CITIBANK N.A.

LOWERPAREL, BOMBAY, MAHARASHTRA, INDIA

 

 

* Date of charge modification

 

 

CONTINGENT LIABILITIES NOT PROVIDED FOR IN RESPECT OF :

(Rs. In Millions)

 

As on 31st March, 2013

As on 31st March, 2012

i) Guarantees given by the company's bankers on behalf of the Company

11.950

5.731

ii) Bills discounted with banks

451.414

337.850

iii) Disputed tax matters

 

 

a) Service tax demand disputed in appeal

3.295

 

3.295

 

b) Excise duty demand disputed in appeal

4.388

 

3.781

c) Demand under drug price control order - 95 ( DPCO – 95 demand disputed in appeal)

59.134

59.134

 

 

FIXED ASSETS

 

Tangible Assets

·         Lease Hold Land

·         Free Hold Land

·         Buildings

·         Plant and Machinery

·         Plant and Machinery

·         Tube Well

·         Office Equipments

·         Computers

·         Vehicles

 

 

UNAUDITED FINANCIAL RESULTS FOR QUARTER ENDED 30th JUNE, 2013

(Rs. in Millions)

 

30.06.2013

 

Unaudited

Net Sales / Income from Operations

581.000

Other Operating Income

16.000

Total Income from operations

597.000

Expenditure

 

Changes in Inventories of Finished Goods, Work-in- Progress and stocks- in-trade

(25.600)

Cost of Materials Consumed

386.900

Purchase of Stock- in - trade

6.000

Employee Benefits Expenses

52.400

Depreciation

30.300

Other Expenses

99.000

Total Expenses

549.000

Profit (Loss) from operations before other income, Interest and exceptional items

48.000

Other Income

10.600

Profit (Loss) before Interest and exceptional items

58.600

Finance Cost

30.700

Profit (Loss) before exceptional items

27.900

Exceptional items

-

Profit ( Loss ) before tax

27.900

Less :Tax expenses

-

Net Profit for the period

27.900

Paid up equity share Capital (Face value Rs 10/-)

390.500

Reserves excluding Revaluation Reserve as per balance sheet of previous accounting year

-

Earning Per Share ( EPS ) before and after Exceptional Item

 

a) Basic

0.71

b) Diluted

0.71

Part II

 

(A) PARTICULARS OF SHAREHOLDING

 

Public shareholding

 

Number of shares

23956538

Percentage of shareholding

61.35%

Promoters and Promoter Group Shareholding

 

a) Pledged / Encumbered

 

Number of shares

1852500

Percentage of shares (as a % of the total shareholding of promoter and promoter group)

12.27%

Percentage of shares (as a % of the total share capital of the company)

4.74%

b) Non - encumbered

 

Number of shares

13240428

Percentage of shares (as a % of the total shareholding of the Promoter and Promoter group)

87.73%

Percentage of shares (as a % of the total share capital of the company)

33.91%

 

 

(B) INVESTOR COMPLAINTS

3 Months ended 30.06.2013

Pending at the beginning of the quarter

-

Received during the quarter

1

Disposed off during the quarter

1

Remaining unresolved at the end of the quarter

-

 

 

REPORTING OF SEGMENT WISE REVENUE, RESULT AND CAPITAL EMPLOYED

 

Particulars

Quarter ended

 

30.06.2013

 

Unaudited

1. Segment Revenue

 

(a) Pharamaceutical

611.000

(b) Consumer Care Division

4.200

Total

615.200

Less : Inter-Segment Revenue

-

Less : Excise Duty

18.200

Net Sales/ Income from Operation

597.000

2. Segment Results

 

(a) Pharamaceutical

61.500

(b) Consumer Care Division

(2.900)

Total

58.600

Less: Finance Cost

30.700

Total Profit Before Tax

27.900

3. Capital Employed

 

(a) Pharamaceutical

1816.700

(b) Consumer Care Division

3.500

(c) Others (Unallocated)

548.100

Total

2368.300

 

 

Notes:

 

(1) The above results were reviewed by the Audit Committee and taken on record by the Board of Directors of the Company at it's meeting held on 10th August, 2013. Limited review has been carried out by statutory auditor of the company.

 

(2) During the quarter the company has launched Tooth Paste under "Sparkle" brand in consumer care division.

 

(3) Auditors observation:

 

a) Investments and Advances made to Subsidiary Company, Kopran Research Laboratories Limited (KRLL) as at 30-06-2013 amounting to Rs. 529.453 Millions, (as at 30.06.2012 Rs.519.238 Millions) are in the opinion of the Auditors doubtful of realisation. In the opinion of the Management, no provision is required to be made because the investment in the Subsidiary Company, KRLL, is long term, for strategic reasons.

 

(4) Other Income includes net exchange Gain of Rs.10.385 Millions (quarter ended 30th June 2012 Gain of Rs.1.398 Millions)

 

(5) Figures for the previous accounting period have been regrouped wherever necessary.


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.61.69

UK Pound

1

Rs.98.59

Euro

1

Rs.83.67

 

 

INFORMATION DETAILS

 

Report Prepared by :

VRN

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

5

--PROFITABILIRY

1~10

5

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

5

--CREDIT LINES

1~10

5

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

YES

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

YES

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

 

 

 

TOTAL

 

46

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.